TO Advance a Novel Beta-Lactamase Inhibitor of Penicillin Binding Proteins Targeting Mdr-Acinetobacter Baumannii
Contract Overview
Contract Amount: $25,044,893 ($25.0M)
Contractor: Venatorx Pharmaceuticals Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2020-07-01
End Date: 2027-01-18
Contract Duration: 2,392 days
Daily Burn Rate: $10.5K/day
Official Description: TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Place of Performance
Location: Pennsylvania, 19355